Kelly Moynihan was a member of the winning team in the Merck KGaA Biopharma Innovation Cup 2017!
The winning team “Immuno-Oncology” received €20,000 for its innovative idea around the role of Natural Killer (NK) cells in cancer immunology.
Biopharma Innovation Cup 2017
Mariane Melo was awarded a 2017 MIT Infinite Mile Award!
Kelly Moynihan was an honoree at the 2017 celebration of Graduate Women of Excellence!
Talar Tokatlian was a recipient of a 2016 Scripps CHAVI-ID Young Investigator Award at the annual All-Investigators Retreat in La Jolla, CA!
Left to right: Darrell Irvine, Talar Tokatlian, Tyson Moyer
Kelly Moynihan's research was featured on the MIT website front page! (and also published in Nature Medicine!)
Anasuya Mandal's research profile was featured on the MIT website front page!
Grand Prize winner at MIT Polymer Day 2016
Congratulations to Anasuya Mandal for being awarded the Grand Prize at MIT Polymer Day 2016 for her poster "Microneedle-Based Immune Monitoring Platform Samples Cells and Interstitial Fluid from Tissue in Situ"
Dr. Szeto and 6 Irvine Lab undergraduate trainees used a novel microfluidic device developed at MIT (Armon Sharei, Langer/Jensen Labs) as a protein loading platform for B cells.
Annual Koch Institute Image Award 2015
Congratulations to Sudha Kumari and Yiran Zheng on winning the 2015 Annual KI image award for their image "License to kill: Empowering the immune system to fight cancer".
Congratulations to Gregtory Szeto and Adelaide Tovar on winning the 2015 Annual KI image award for their image "Easy breezy: Particles prop open therapeutic windows".
Congratulations to Dr. Peter DeMuth on winning the first prize of international Quadrant Award on January 30, 2015.
BMES Annual Meeting 2014
Congratulations to Anasuya Mandal on receiving the Reviewer Choice Award for her poster at the Biomedical Engineering Society 2014 meeting in the Biomaterials track.
Koch Institute for Integrative Cancer Research, May 28, 2014
A team led by KI faculty member Darrell Irvine, along with Dana-Farber Cancer Institute investigators Kai Wucherpfennig and Michael Goldberg, received the Melanoma Research Alliance (MRA) Team Science Award to optimize T cell-targeting nanoparticles for improved melanoma treatment. The Team Science Award Program is the centerpiece of the MRA research funding portfolio and aims to promote collaborative, interdisciplinary, transformational melanoma research advances with the potential for rapid clinical translation. As such, it is no surprise that this team came together through the Bridge Project, a collaboration between the Koch Institute and Dana-Farber/Harvard Cancer Center designed to unite bioengineering, advanced cancer science, and clinical oncology to solve challenging problems in cancer research and care. The team's project was among the ten finalists in this year’s round of Bridge Project funding, and speaks to the power of the Bridge Project to establish new connections between unmet clinical needs and innovative technological solutions. Congratulations!